prednisolone phosphate has been researched along with methylprednisolone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jurs, PC; Stouch, TR | 1 |
Bodor, N; Harget, AJ; Phillips, EW | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bennett, FM | 1 |
Banciu, M; Fens, MH; Schiffelers, RM; Storm, G | 1 |
Banciu, M; Metselaar, JM; Schiffelers, RM; Storm, G | 1 |
6 other study(ies) available for prednisolone phosphate and methylprednisolone
Article | Year |
---|---|
Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.
Topics: Anti-Inflammatory Agents; Humans; Numerical Analysis, Computer-Assisted; Steroids; Structure-Activity Relationship; Vasoconstriction | 1986 |
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.
Topics: Animals; Anti-Inflammatory Agents; Drug Synergism; Granuloma; Humans; Models, Chemical; Rats; Steroids; Structure-Activity Relationship; Vasoconstriction | 1983 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
VOGT-KOYANAGI DISEASE.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methylprednisolone; Methylprednisolone Acetate; Prednisolone; Uveomeningoencephalitic Syndrome; Visual Acuity | 1962 |
Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Budesonide; Dexamethasone; Dose-Response Relationship, Drug; Liposomes; Male; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred C57BL; Organ Size; Prednisolone; Spleen | 2008 |
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Topics: Animals; Budesonide; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelium, Vascular; Glucocorticoids; Inflammation; Injections, Subcutaneous; Liposomes; Male; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred C57BL; Nanomedicine; Neovascularization, Pathologic; Prednisolone; Receptors, Glucocorticoid; Time Factors; Tumor Burden; Umbilical Veins | 2008 |